Elisha Nathan

Elisha Nathan has had a diverse work experience in various companies and roles. Starting in 2003, they worked as a software developer at Israel Aircraft Industry until 2005. They then pursued a career in business development, starting as a Director of Business Development at Protalix Biotherapiutics from 2010 to 2014. Following that, they served as a Director of Business Development at Evogene from 2014 to 2015. Elisha then moved on to Ramot at Tel Aviv University Ltd., where they held the position of Director of Business Development from 2015 to 2018, and later became the VP of Business Development from 2018 to 2018. After that, they joined CytoReason as the VP of Strategic Alliances from 2018 to 2023. Currently, Elisha is working as a Business Development Consultant for Bina - Bridge Innovate Nurture Advance. Additionally, they are set to join Immunai in 2023 as the VP of Strategic Alliances.

Elisha Nathan completed a Doctor of Philosophy (PhD) degree in Molecular Genetics from the Weizmann Institute of Science between 2005 and 2009. In addition, from 2007 to 2009, they also pursued a Master of Business Administration (MBA) degree specializing in Finance, General at Bar-Ilan University.